Effectiveness and long-term retention of anti-tumour necrosis factor treatment in juvenile and adult patients with juvenile idiopathic arthritis: data from Reuma.pt-Reference-Cited by-同舟云学术

Effectiveness and long-term retention of anti-tumour necrosis factor treatment in juvenile and adult patients with juvenile idiopathic arthritis: data from Reuma.pt

Published:2015-12-15 Issue:4 Volume:55 Page:697-703
ISSN:1462-0324
Container-title:Rheumatology
language:en
Short-container-title:Rheumatology

Author:

Mourão Ana F.,Santos Maria J.,Melo Gomes José A.,Martins Fernando M.,Mendonça Sílvia C.,Oliveira Ramos Filipa,Fernandes Susana,Salgado Manuel,Guedes Margarida,Carvalho Sónia,Costa José A.,Brito Iva,Duarte Cátia,Furtado Carolina,Lopes Ana,Rodrigues Ana,Sequeira Graça,Branco Jaime C.,Fonseca João E.,Canhão Helena

Publisher

Oxford University Press (OUP)

Subject

Pharmacology (medical),Rheumatology

Reference36 articles.

1. International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001;Petty;J Rheumatol,2004

2. Etanercept in Children with Polyarticular Juvenile Rheumatoid Arthritis

3. Safety and efficacy of up to eight years of continuous etanercept therapy in patients with juvenile rheumatoid arthritis

4. Adalimumab with or without Methotrexate in Juvenile Rheumatoid Arthritis

5. A randomized, placebo-controlled trial of infliximab plus methotrexate for the treatment of polyarticular-course juvenile rheumatoid arthritis

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Epidemiology and comorbidity of juvenile idiopathic arthritis in Poland – a nationwide study;2024-07-27

2. Revising diagnosis of juvenile idiopathic arthritis in adults: a single-center retrospective study;Rheumatology International;2023-03-01

3. The Role of Serum Calprotectin in Defining Disease Outcomes in Non-Systemic Juvenile Idiopathic Arthritis: A Pilot Study;International Journal of Molecular Sciences;2023-01-14

4. Treatment Response to Tumor Necrosis Factor Inhibitors and Methotrexate Monotherapy in Adults With Juvenile Idiopathic Arthritis: Data From NOR-DMARD;The Journal of Rheumatology;2022-11-15

5. Persistence and adherence to biologic therapies in juvenile idiopathic arthritis;Scientific Reports;2021-08-10